Cost minimization analysis of two chemotherapy regimens in the treatment of colorectal cancer in a public reimbursement hospital in Brazil
Objective: To conduct a pharmacoeconomic evaluation between XELOX and mFOLFOX6 in the adjuvant and metastatic treatment of colorectal cancer from the perspective of a public reimbursement hospital. Methods: The cost minimization analysis was conducted for patients who started treatment in 2013 and...
Guardado en:
Autores principales: | Sara C. BOSCATO, Márcia R. GODOY, Isabela HEINECK |
---|---|
Formato: | article |
Lenguaje: | EN PT |
Publicado: |
Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dcac267a47ea48cb9ed155b9b1f77a35 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Interventions performed by clinical pharmacist in the renal transplant ambulatory care
por: Diego Gnatta, et al.
Publicado: (2020) -
Guest editorial: The ten most important qualities for the profession of medicinal research
por: Tony Y. Zhang
Publicado: (2021) -
Correction: Structural Racism and Supporting Black Lives – A Pharmacist’s Vow amid COVID-19
por: Nicole D. Avant
Publicado: (2021) -
An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
por: Manal Mohammed Younus, et al.
Publicado: (2021) -
Pharmacy-Based Point-of-Care Testing: How a “Standard of Care” Approach Can Facilitate Sustainability
por: Alex J. Adams, et al.
Publicado: (2021)